Lonza announces first GMP batch completion at next-generation mammalian manufacturing facility in US
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
The collaboration offers opportunities for training, research fellowships, workshops and conferences at palliative care centers managed by Ajit Isaac Foundation
New research labs and process development services to enable next generation therapeutics
Dr. Muthu was last associated with Mankind Pharma
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
Roger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer
Emcure has launched an awareness campaign to help spread the word about male anemia
Jagsonpal Pharmaceuticals has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration formalities
Recommendation based on LAURA Phase III trial results which showed Tagrisso extended median progression-free survival to more than three years
Subscribe To Our Newsletter & Stay Updated